US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 776.380
- -29.680-3.68%
Close Nov 6 16:00 ET
- 775.000
- -1.380-0.18%
Post 17:33 ET
737.03BMarket Cap83.93P/E (TTM)
820.730High767.610Low8.25MVolume817.330Open806.060Pre Close6.40BTurnover0.87%Turnover Ratio133.86P/E (Static)949.32MShares972.53052wk High51.76P/B736.23BFloat Cap558.92052wk Low5.03Dividend TTM948.29MShs Float972.530Historical High0.65%Div YieldTTM6.59%Amplitude5.287Historical Low776.128Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Ralph Alvarez
- Independent Director
- 336.00K
- Jon Erik Fyrwald
- Independent Director
- 344.88K
- Jamere Jackson
- Independent Director
- 345.00K
- Katherine Baicker
- Independent Director
- 336.00K
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Karen Walker
- Independent Director
- 359.00K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
